MoneyWorks4Me

The sales declined to Rs. 705.66 millions for the June 2025 quarter as compared to Rs. 893.56 millions during the corresponding quarter last year.The Company to register a -57.88%  fall in the net profit for the quarter ended June 2025.Operating Profit reported a sharp decline to 113.82 millions from 239.40 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 705.66 893.56 -21.03 705.66 893.56 -21.03 3457.68 3624.62 -4.61
Other Income 220.36 230.62 -4.45 220.36 230.62 -4.45 295.81 575.52 -48.60
PBIDT 113.82 239.40 -52.46 113.82 239.40 -52.46 326.07 1044.32 -68.78
Interest 5.55 0.93 496.77 5.55 0.93 496.77 4.10 3.21 27.73
PBDT 108.27 238.47 -54.60 108.27 238.47 -54.60 321.97 1041.11 -69.07
Depreciation 23.89 17.85 33.84 23.89 17.85 33.84 69.69 68.25 2.11
PBT 84.38 220.62 -61.75 84.38 220.62 -61.75 252.28 972.86 -74.07
TAX 5.01 32.18 -84.43 5.01 32.18 -84.43 80.27 218.66 -63.29
Deferred Tax 5.01 20.36 -75.39 5.01 20.36 -75.39 21.03 42.76 -50.82
PAT 79.37 188.44 -57.88 79.37 188.44 -57.88 172.01 754.20 -77.19
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) 16.13 26.79 -39.80 16.13 26.79 -39.80 9.43 28.81 -67.27
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..